Genenta Science (GNTA)

• Market cap: $16.9M
• 1 day: 8.19%
• 5 days: -15.79%
• 1 month: -24.14%
• 3 months: -50.68%
• 6 months: -77.14%
• Year to date: -48.94%
• 1 year: -82.04%
• 5 years: -93.45%
• 10 years: -93.45%
• Sector: Healthcare
• Industry: Biotechnology

About: Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Employees: 13